Differences in growth characteristics and elementary body associated cytotoxicity between Chlamydia trachomatis oculogenital serovars D and H and Chlamydia muridarum

Journal of Clinical Pathology

Volumn 58, Issue 4, 2005, Pages 397-401

  Lyons, J M ^a   Ito Jr , J I ^a   Pena A S ^b   Morre S A ^b  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LACTATE DEHYDROGENASE;

ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CELL INCLUSION; CHLAMYDIA; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; CYTOTOXICITY; DNA REPLICATION; FEMALE; GENITAL TRACT INFECTION; IN VITRO STUDY; MICROSCOPY; MONOLAYER CULTURE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEROTYPE;

CELL CYCLE; CHLAMYDIA INFECTIONS; CHLAMYDIA MURIDARUM; CHLAMYDIA TRACHOMATIS; CULTURE MEDIA; CYTOTOXINS; FEMALE; GENITAL DISEASES, FEMALE; HUMANS; INCLUSION BODIES; L-LACTATE DEHYDROGENASE; SEROTYPING; VIRULENCE;

EID: 17144432311     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2004.021543     Document Type: Article

References (30)

1. Morré SA, Ossewaarde JM, Lan J, et al. Serotyping and genotyping of genital Chlamydia trachomatis isolates reveal variants of serovar Ba, G, and J as confirmed by omp1 nucleotide sequence analysis. J Clin Microbiol 1998;36:345-51.
2. Geisler WM, Suchland RJ, Whittington WL, et al. The relationship of serovar to clinical manifestations of urogenital Chlamydia trachomatis infection. Sex Transm Dis 2003;30:160-5.
3. Barnes RC, Rompalo AM, Stamm WE. Comparison of Chlamydia trachomatis serovars causing rectal and cervical infections. J Infect Dis 1987;156:953-8.
4. Kuo CCC, Wang SP, Holmes KK, et al. Immunotypes of Chlamydia trachomatis isolates in Seattle, Washington. Infect Immun 1983;41:865-8.
5. Mabey DC, Forsey WT, Treharne JD. Serotypes of Chlamydia trachomatis in The Gambia. Lancet 1987;2:452.
6. Wagenvoort JHT, Suchland RJ, Stamm WE. Serovar distribution of urogenital Chlamydia trachomatis strains in The Netherlands. Genitourin Med 1988;64:159-61.
7. Morré SA, Rozendaal L, van Valkengoed IG, et al. Urogenital Chlamydia trachomatis serovars in men and women with a symptomatic or asymptomatic infection: an association with clinical manifestations? J Clin Microbiol 2000;38:2292-6.
8. Suchland RJ, Eckert LO, Hawes SE, et al. Longitudinal assessment of infecting serovars of Chlamydia trachomatis in Seattle public health clinics: 1988-1996. Sex Transm Dis 2003;30:357-61.
9. Spaargaren J, Verhaest I, Mooij S, et al. Analysis of Chlamydia trachomatis serovar distribution changes in the Netherlands (1986-2002). Sex Transm Infect 2004;80:151-2.
10. Eckert LO, Suchland RJ, Hawes SE, et al. Quantitative Chlamydia trachomatis cultures: correlation of chlamydial inclusion-forming units with serovar, age, sex, and race. J Infect Dis 2000;182:540-4.
11. Parley TA, Cohen DA, Elkins W. Asymptomatic sexually transmitted diseases: the case for screening. Prev Med 2003;36:502-9.
12. Tuffrey M, Taylor-Robinson D. Progesterone as a key factor in the development of a mouse model for genital-tract infection with Chlamydia trachomatis. FEMS Microbiol Lett 1981;12:111-15.
13. Everett KD, Bush RM, Andersen AA. Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms. Int J Syst Bacteriol 1999;49:415-40.
14. Morrison RP. Differential sensitivities of Chlamydia trachomatis strains to inhibitory effects of gamma interferon. Infect Immun 2000;68:6038-40.
15. Caldwell HD, et al. Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates. J Clin Invest 2003;111:1757-69.
16. Belland RJ, Scidmore MA, Crane DD, et al. Chlamydia trachomatis cytotoxicity associated with complete and partial cytotoxin genes. Proc Natl Acad Sci U S A 2001;98:13984-9.
17. Johansson M, Schon K, Ward M, et al. Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response. Infect Immun 1997;65:1032-44.
18. Perry LL, Su H, Feilzer K, et al. Differential sensitivities of distinct Chlamydia trachomatis isolates to INF-g mediated inhibition. J Immunol 1999;162:3541-8.
19. Ito JI, Lyons JM. Role of gamma interferon in controlling murine chlamydial genital tract infection. Infect Immun 1999;67:5518-21.
20. Ito JI, Lyons JM, Airo-Brown LP. Variation in virulence among oculogenital serovars of Chlamydia trachomatis in experimental genital tract infection. Infect Immun 1990;58:2021-3.
21. Ripa KT, Mardh P-A. Cultivation of Chlamydia trachomatis in cycloheximide-treated McCoy cells. J Clin Microbiol 1977;6:328-31.
22. Howard L, Orenstein NS, King NW. Purification on Renografin density gradients of Chlamydia trachomatis grown in the yolk sac of eggs. Appl Microbiol 1974;27:102-6.
23. Morrison RP, Caldwell HD. Immunity to murine chlamydial genital infection. Infect Immun 2002;70:2741-51.
24. Johansson M, Ward M, Lycke N. B-cell-deficient mice develop complete immune protection against genital tract infection with Chlamydia trachomatis. Immunology 1997;92:422-8.
25. Stogg AJ, Tuffrey M, Woods C, et al. Protection against ascending infection of the genital tract by Chlamydia trachomatis is associated with recruitment of major histocompatibility complex class II antigen-presenting cells into uterine tissue. Infect Immun 1998;66:3535-44.
26. Ramsey KH, DeWolfe JL, Salyer RD. Disease outcome subsequent to primary and secondary urogenital infection with murine or human biovars of Chlamydia trachomatis. Infect Immun 2000;68:7186-9.
27. Darville T, Andrews CW, Laffoon KK, et al. Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response. Infect Immun 1997;65:3065-73.
28. de la Maza LM, Pal S, Khamesipour A, et al. Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility. Infect Immun 1994;62:2094-7.
29. van Valkengoed IG, Morre SA, van den Brule AJ, et al. Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes-implications for cost-effectiveness analyses. Int J Epidemiol 2004;33:416-25.
30. Morré SA, Lyons JM, Ito JI Jr. Murine models of Chlamydia trachomatis genital tract infection: use of mouse pneumonitis strain versus human strains. Infect Immun 2000;68:7209-11.